Trientine
Back to searchMolecule Structure
Scientific Name
Trientine
Description of the Drug
Triethylenetetramine is a copper chelating agent used for the management of Wilson’s disease in cases where penicillamine therapy is clinically inappropriate.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06824
http://www.drugbank.ca/drugs/DB06824
Brand Name(s)
Not Available
Company Owner(s)
Msn Laboratories Private Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Pharma Life Sciences Llc, Par Pharmaceutical Inc, Chartwell Rx Sciences Llc, Hetero Labs Ltd Unit Iii, Navinta Llc, Orphalan Sa, Accord Healthcare Inc, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Copper | METAL | CHELATING AGENT | CHEMBL2363057 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15439 | ||
| Human Metabolome Database | HMDB0259196 | ||
| DrugBank | DB06824 | ||
| PubChem: Thomson Pharma | 15297406 | ||
| PubChem | 5565 | ||
| Mcule | MCULE-3203769500 | ||
| LINCS | LSM-45752 | ||
| Nikkaji | J5.120I | ||
| PDBe | 104 | ||
| BindingDB | 50323751 | ||
| EPA CompTox Dashboard | DTXSID9023702 | ||
| DrugCentral | 2738 | ||
| Brenda | 10799 | ||
| ChemicalBook | CB8183772 | ||
| rxnorm | TRIENTINE | TRIENTINE HYDROCHLORIDE | SYPRINE |
| KEGG Ligand | C07166 | ||
| ChEBI | 39501 | ||
| ZINC | ZINC000019364225 |
